Published in PLoS Genet on December 01, 2011
Plectin-intermediate filament partnership in skin, skeletal muscle, and peripheral nerve. Histochem Cell Biol (2013) 1.17
Plakins, a versatile family of cytolinkers: roles in skin integrity and in human diseases. J Invest Dermatol (2013) 1.01
Intermediate filament-associated cytolinker plectin 1c destabilizes microtubules in keratinocytes. Mol Biol Cell (2013) 0.90
Plectin mutations underlie epidermolysis bullosa simplex in 8% of patients. J Invest Dermatol (2013) 0.87
Properties of intermediate filament networks assembled from keratin 8 and 18 in the presence of Mg²+. Biophys J (2012) 0.87
UV exposure modulates hemidesmosome plasticity, contributing to long-term pigmentation in human skin. J Pathol (2015) 0.84
Molecular architecture and function of the hemidesmosome. Cell Tissue Res (2014) 0.83
The rod domain is not essential for the function of plectin in maintaining tissue integrity. Mol Biol Cell (2015) 0.81
Phosphorylation of serine 4,642 in the C-terminus of plectin by MNK2 and PKA modulates its interaction with intermediate filaments. J Cell Sci (2013) 0.80
Cytoplasmic plaque formation in hemidesmosome development is dependent on SoxF transcription factor function. PLoS One (2012) 0.79
Molecular architecture and function of the hemidesmosome. Cell Tissue Res (2015) 0.77
Interaction of plectin with keratins 5 and 14: dependence on several plectin domains and keratin quaternary structure. J Invest Dermatol (2014) 0.77
Structural insights into Ca2+-calmodulin regulation of Plectin 1a-integrin β4 interaction in hemidesmosomes. Structure (2015) 0.75
A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res (2001) 124.61
HPRT-deficient (Lesch-Nyhan) mouse embryos derived from germline colonization by cultured cells. Nature (1987) 10.32
Electrophoretic analysis of plasminogen activators in polyacrylamide gels containing sodium dodecyl sulfate and copolymerized substrates. Anal Biochem (1980) 7.23
The development of proteasome inhibitors as anticancer drugs. Cancer Cell (2004) 4.46
Gene targeting of BPAG1: abnormalities in mechanical strength and cell migration in stratified epithelia and neurologic degeneration. Cell (1995) 2.75
Plectin sidearms mediate interaction of intermediate filaments with microtubules and other components of the cytoskeleton. J Cell Biol (1996) 2.35
Targeted inactivation of plectin reveals essential function in maintaining the integrity of skin, muscle, and heart cytoarchitecture. Genes Dev (1997) 2.32
Role of plectin in cytoskeleton organization and dynamics. J Cell Sci (1998) 2.01
Differential inhibition of calpain and proteasome activities by peptidyl aldehydes of di-leucine and tri-leucine. J Biochem (1996) 2.00
The proteasome inhibitor PS-341 in cancer therapy. Clin Cancer Res (1999) 1.94
Current insights into the formation and breakdown of hemidesmosomes. Trends Cell Biol (2006) 1.79
Linking integrin alpha6beta4-based cell adhesion to the intermediate filament cytoskeleton: direct interaction between the beta4 subunit and plectin at multiple molecular sites. J Cell Biol (1998) 1.79
Plectin deficiency results in muscular dystrophy with epidermolysis bullosa. Nat Genet (1996) 1.78
Not just scaffolding: plectin regulates actin dynamics in cultured cells. Genes Dev (1998) 1.71
A hypomorphic mouse model of dystrophic epidermolysis bullosa reveals mechanisms of disease and response to fibroblast therapy. J Clin Invest (2008) 1.67
Binding of integrin alpha6beta4 to plectin prevents plectin association with F-actin but does not interfere with intermediate filament binding. J Cell Biol (1999) 1.64
The emerging roles of serine protease cascades in the epidermis. Trends Biochem Sci (2009) 1.64
Dynamic relationship of focal contacts and hemidesmosome protein complexes in live cells. J Invest Dermatol (2010) 1.52
Analysis of the interactions between BP180, BP230, plectin and the integrin alpha6beta4 important for hemidesmosome assembly. J Cell Sci (2003) 1.52
Desmoplakin I and desmoplakin II. Purification and characterization. J Biol Chem (1989) 1.49
Occurrence and immunolocalization of plectin in tissues. J Cell Biol (1983) 1.47
Cytoplasmic network arrays demonstrated by immunolocalization using antibodies to a high molecular weight protein present in cytoskeletal preparations from cultured cells. Exp Cell Res (1982) 1.47
Plectin-controlled keratin cytoarchitecture affects MAP kinases involved in cellular stress response and migration. J Cell Biol (2006) 1.46
Defective expression of plectin/HD1 in epidermolysis bullosa simplex with muscular dystrophy. J Clin Invest (1996) 1.45
Plectin-RACK1 (receptor for activated C kinase 1) scaffolding: a novel mechanism to regulate protein kinase C activity. J Biol Chem (2004) 1.44
Identification of the cytolinker plectin as a major early in vivo substrate for caspase 8 during CD95- and tumor necrosis factor receptor-mediated apoptosis. Mol Cell Biol (2000) 1.40
Plectin 1f scaffolding at the sarcolemma of dystrophic (mdx) muscle fibers through multiple interactions with beta-dystroglycan. J Cell Biol (2007) 1.39
Unusual 5' transcript complexity of plectin isoforms: novel tissue-specific exons modulate actin binding activity. Hum Mol Genet (1999) 1.35
Proteolytic processing of endogenous and recombinant beta 4 integrin subunit. J Cell Biol (1992) 1.34
Calpain mediates excitotoxic DNA fragmentation via mitochondrial pathways in adult brains: evidence from calpastatin mutant mice. J Biol Chem (2005) 1.34
Plectin-isoform-specific rescue of hemidesmosomal defects in plectin (-/-) keratinocytes. J Invest Dermatol (2003) 1.33
Structure and hydrodynamic properties of plectin molecules. J Mol Biol (1987) 1.33
Dynamics of the alpha6beta4 integrin in keratinocytes. Mol Biol Cell (2002) 1.29
Progress in epidermolysis bullosa: the phenotypic spectrum of plectin mutations. Exp Dermatol (2005) 1.25
Myofiber integrity depends on desmin network targeting to Z-disks and costameres via distinct plectin isoforms. J Cell Biol (2008) 1.25
Plectin 5'-transcript diversity: short alternative sequences determine stability of gene products, initiation of translation and subcellular localization of isoforms. Hum Mol Genet (2003) 1.21
Casein zymography: a method to study mu-calpain, m-calpain, and their inhibitory agents. Arch Biochem Biophys (1995) 1.21
Discontinuous native protein gel electrophoresis. Electrophoresis (2006) 1.18
The therapeutic potential of the calpain family: new aspects. Drug Discov Today (2006) 1.17
Expression of trypsin by epithelial cells of various tissues, leukocytes, and neurons in human and mouse. Am J Pathol (1998) 1.17
Demonstration of type II hemidesmosomes in a mammary gland epithelial cell line, BMGE-H. J Biochem (1994) 1.14
Keratin mutations of epidermolysis bullosa simplex alter the kinetics of stress response to osmotic shock. J Cell Sci (2002) 1.11
1,25-Dihydroxyvitamin D3 increases nuclear vitamin D3 receptors by blocking ubiquitin/proteasome-mediated degradation in human skin. Mol Endocrinol (1999) 1.11
Metastatic growth of squamous cell carcinomas is correlated with upregulation and redistribution of hemidesmosomal components. Cell Tissue Res (2001) 1.10
Simultaneous determination of protein aggregation, degradation, and absolute molecular weight by size exclusion chromatography-multiangle laser light scattering. Anal Biochem (2006) 1.08
BPAG1e maintains keratinocyte polarity through beta4 integrin-mediated modulation of Rac1 and cofilin activities. Mol Biol Cell (2009) 1.08
A site-specific plectin mutation causes dominant epidermolysis bullosa simplex Ogna: two identical de novo mutations. J Invest Dermatol (2002) 1.03
Mutation in exon 1f of PLEC, leading to disruption of plectin isoform 1f, causes autosomal-recessive limb-girdle muscular dystrophy. Am J Hum Genet (2010) 1.03
Endogenous calpain-3 activation is primarily governed by small increases in resting cytoplasmic [Ca2+] and is not dependent on stretch. J Biol Chem (2009) 1.02
Plectin. Methods Cell Biol (2004) 1.01
Autolysis parallels activation of mu-calpain. Biochem J (1996) 1.01
Calpain-mediated cleavage of the cyclin-dependent kinase-5 activator p39 to p29. J Biol Chem (2002) 0.99
Calpain mediates eukaryotic initiation factor 4G degradation during global brain ischemia. J Cereb Blood Flow Metab (1998) 0.98
A homozygous nonsense mutation within the dystonin gene coding for the coiled-coil domain of the epithelial isoform of BPAG1 underlies a new subtype of autosomal recessive epidermolysis bullosa simplex. J Invest Dermatol (2010) 0.98
Plectin gene defects lead to various forms of epidermolysis bullosa simplex. Dermatol Clin (2010) 0.95
Plectin isoform-dependent regulation of keratin-integrin alpha6beta4 anchorage via Ca2+/calmodulin. J Biol Chem (2009) 0.95
Conditional targeting of plectin in prenatal and adult mouse stratified epithelia causes keratinocyte fragility and lesional epidermal barrier defects. J Cell Sci (2007) 0.95
Epidermolysis bullosa simplex associated with pyloric atresia is a novel clinical subtype caused by mutations in the plectin gene (PLEC1). J Mol Diagn (2005) 0.93
Proteolytic cleavage of the integrin beta 4 subunit. Exp Cell Res (1994) 0.92
Acquired skin disease of hemidesmosomes. J Dermatol Sci (1999) 0.91
mu-Calpain and calpain-3 are not autolyzed with exhaustive exercise in humans. Am J Physiol Cell Physiol (2005) 0.91
Selective changes in laminin adhesion and alpha 6 beta 4 integrin regulation are associated with the initial steps in keratinocyte maturation. Cell Growth Differ (1996) 0.90
Plectin abnormality in epidermolysis bullosa simplex Ogna: non-responsiveness of basal keratinocytes to some anti-rat plectin antibodies. Exp Dermatol (1997) 0.88
Plectin expression patterns determine two distinct subtypes of epidermolysis bullosa simplex. Hum Mutat (2010) 0.88
Hemidesmosomes show abnormal association with the keratin filament network in junctional forms of epidermolysis bullosa. J Invest Dermatol (1998) 0.88
Congenital myasthenic syndrome associated with epidermolysis bullosa caused by homozygous mutations in PLEC1 and CHRNE. Clin Genet (2010) 0.87
Calpains, skeletal muscle function and exercise. Clin Exp Pharmacol Physiol (2009) 0.87
Regulation of the type II hemidesmosomal plaque assembly in intestinal epithelial cells. Exp Cell Res (1999) 0.85
Brain mu-calpain autolysis during global cerebral ischemia. J Neurochem (1996) 0.84
Epiplakin is dispensable for skin barrier function and for integrity of keratin network cytoarchitecture in simple and stratified epithelia. Mol Cell Biol (2006) 0.84
Plakin proteins are coordinately cleaved during apoptosis but preferentially through the action of different caspases. Exp Dermatol (2004) 0.84
Co-assembly of envoplakin and periplakin into oligomers and Ca(2+)-dependent vesicle binding: implications for cornified cell envelope formation in stratified squamous epithelia. J Biol Chem (2004) 0.83
Upregulation of the calcium-dependent protease, calpain, during keratinocyte differentiation. Br J Dermatol (1998) 0.82
Comparative study of protein molecular weights by size-exclusion chromatography and laser-light scattering. J Pharm Biomed Anal (2001) 0.82
Epidermolysis bullosa simplex with muscular dystrophy. Dermatol Clin (2010) 0.82
The calcium-activated neutral protease calpain I is present in normal foetal skin and is decreased in neonatal harlequin ichthyosis. Br J Dermatol (1999) 0.81
Restriction of microM-calcium-requiring calpain activation to the plasma membrane in human neuroblastoma cells: evidence for regionalized influence of a calpain activator protein. J Neurosci Res (1997) 0.81
Disulfide bond within mu-calpain active site inhibits activity and autolysis. Biochim Biophys Acta (2008) 0.80
Expression of plectin and HD1 epitopes in patients with epidermolysis bullosa simplex associated with muscular dystrophy. Arch Dermatol Res (1999) 0.79
Proteolysis of liver plectin by mu-calpain. Biochem Biophys Res Commun (1998) 0.79
Inflammatory bowel disease and mutations affecting the interleukin-10 receptor. N Engl J Med (2009) 7.53
A homozygous CARD9 mutation in a family with susceptibility to fungal infections. N Engl J Med (2009) 5.20
A syndrome with congenital neutropenia and mutations in G6PC3. N Engl J Med (2009) 2.30
Distinct Epidemiology and Clinical Consequence of Classic Versus Rare EGFR Mutations in Lung Adenocarcinoma. J Thorac Oncol (2015) 2.17
Soluble BAFF levels inversely correlate with peripheral B cell numbers and the expression of BAFF receptors. J Immunol (2011) 2.08
B-cell activating factor receptor deficiency is associated with an adult-onset antibody deficiency syndrome in humans. Proc Natl Acad Sci U S A (2009) 1.95
Deleterious mutations in LRBA are associated with a syndrome of immune deficiency and autoimmunity. Am J Hum Genet (2012) 1.94
Circulating CD21low B cells in common variable immunodeficiency resemble tissue homing, innate-like B cells. Proc Natl Acad Sci U S A (2009) 1.91
Reexamining the role of TACI coding variants in common variable immunodeficiency and selective IgA deficiency. Nat Genet (2007) 1.87
Genetic CD21 deficiency is associated with hypogammaglobulinemia. J Allergy Clin Immunol (2011) 1.86
Chromosomal imbalances in primary and metastatic melanomas: over-representation of essential telomerase genes. Melanoma Res (2003) 1.83
TorsinA binds the KASH domain of nesprins and participates in linkage between nuclear envelope and cytoskeleton. J Cell Sci (2008) 1.80
5' trans-splicing repair of the PLEC1 gene. J Invest Dermatol (2007) 1.77
Hedgehog partial agonism drives Warburg-like metabolism in muscle and brown fat. Cell (2012) 1.65
DNA damage, somatic aneuploidy, and malignant sarcoma susceptibility in muscular dystrophies. PLoS Genet (2011) 1.65
Human ICOS deficiency abrogates the germinal center reaction and provides a monogenic model for common variable immunodeficiency. Blood (2005) 1.63
Transmembrane activator and calcium-modulating cyclophilin ligand interactor mutations in common variable immunodeficiency: clinical and immunologic outcomes in heterozygotes. J Allergy Clin Immunol (2007) 1.62
Down-regulation of Sprouty2 in non-small cell lung cancer contributes to tumor malignancy via extracellular signal-regulated kinase pathway-dependent and -independent mechanisms. Mol Cancer Res (2007) 1.52
The LETM1/YOL027 gene family encodes a factor of the mitochondrial K+ homeostasis with a potential role in the Wolf-Hirschhorn syndrome. J Biol Chem (2004) 1.49
A Mek1-Mek2 heterodimer determines the strength and duration of the Erk signal. Nat Struct Mol Biol (2009) 1.48
Plectin-controlled keratin cytoarchitecture affects MAP kinases involved in cellular stress response and migration. J Cell Biol (2006) 1.46
Plectin-RACK1 (receptor for activated C kinase 1) scaffolding: a novel mechanism to regulate protein kinase C activity. J Biol Chem (2004) 1.44
A binding motif for Siah ubiquitin ligase. Proc Natl Acad Sci U S A (2003) 1.43
Trivanillic polyphenols with anticancer cytostatic effects through the targeting of multiple kinases and intracellular Ca2+ release. J Cell Mol Med (2012) 1.40
Increased hydrophobicity at the N terminus/membrane interface impairs gating of the severe combined immunodeficiency-related ORAI1 mutant. J Biol Chem (2009) 1.39
Plectin 1f scaffolding at the sarcolemma of dystrophic (mdx) muscle fibers through multiple interactions with beta-dystroglycan. J Cell Biol (2007) 1.39
Haloquadratum walsbyi: limited diversity in a global pond. PLoS One (2011) 1.37
Downregulation of TSLC1 and DAL-1 expression occurs frequently in breast cancer. Breast Cancer Res Treat (2007) 1.35
Green tea extract and (-)-epigallocatechin-3-gallate, the major tea catechin, exert oxidant but lack antioxidant activities. FASEB J (2005) 1.35
Common variable immunodeficiency: an update. Arthritis Res Ther (2012) 1.33
Plectin-isoform-specific rescue of hemidesmosomal defects in plectin (-/-) keratinocytes. J Invest Dermatol (2003) 1.33
CX, an algorithm that identifies protruding atoms in proteins. Bioinformatics (2002) 1.33
Anticancer activity of metal complexes: involvement of redox processes. Antioxid Redox Signal (2011) 1.32
Impact of metal coordination on cytotoxicity of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (triapine) and novel insights into terminal dimethylation. J Med Chem (2009) 1.32
Loss of nucleoplasmic LAP2alpha-lamin A complexes causes erythroid and epidermal progenitor hyperproliferation. Nat Cell Biol (2008) 1.30
DPX: for the analysis of the protein core. Bioinformatics (2003) 1.29
LEM2 is a novel MAN1-related inner nuclear membrane protein associated with A-type lamins. J Cell Sci (2005) 1.28
Plectin isoform 1b mediates mitochondrion-intermediate filament network linkage and controls organelle shape. J Cell Biol (2008) 1.28
Plectin scaffolds recruit energy-controlling AMP-activated protein kinase (AMPK) in differentiated myofibres. J Cell Sci (2006) 1.27
KP1019, a new redox-active anticancer agent--preclinical development and results of a clinical phase I study in tumor patients. Chem Biodivers (2008) 1.27
Plectin regulates the organization of glial fibrillary acidic protein in Alexander disease. Am J Pathol (2006) 1.25
Myofiber integrity depends on desmin network targeting to Z-disks and costameres via distinct plectin isoforms. J Cell Biol (2008) 1.25
Interaction between fatty acid synthase- and ErbB-systems in ovarian cancer cells. Biochem Biophys Res Commun (2009) 1.25
Resistance against novel anticancer metal compounds: differences and similarities. Drug Resist Updat (2008) 1.24
Atom depth as a descriptor of the protein interior. Biophys J (2003) 1.24
Impact of rituximab on immunoglobulin concentrations and B cell numbers after cyclophosphamide treatment in patients with ANCA-associated vasculitides. PLoS One (2012) 1.23
Fibroblast growth factor receptor-mediated signals contribute to the malignant phenotype of non-small cell lung cancer cells: therapeutic implications and synergism with epidermal growth factor receptor inhibition. Mol Cancer Ther (2008) 1.23
Floral adaptation to local pollinator guilds in a terrestrial orchid. Ann Bot (2013) 1.22
The sodium pump alpha1 sub-unit: a disease progression-related target for metastatic melanoma treatment. J Cell Mol Med (2009) 1.21
Plectin 5'-transcript diversity: short alternative sequences determine stability of gene products, initiation of translation and subcellular localization of isoforms. Hum Mol Genet (2003) 1.21
Plectin-intermediate filament partnership in skin, skeletal muscle, and peripheral nerve. Histochem Cell Biol (2013) 1.17
Trichoplein/mitostatin regulates endoplasmic reticulum-mitochondria juxtaposition. EMBO Rep (2010) 1.15
Unique features of the sodC-encoded superoxide dismutase from Mycobacterium tuberculosis, a fully functional copper-containing enzyme lacking zinc in the active site. J Biol Chem (2004) 1.15
The many faces of plectin and plectinopathies: pathology and mechanisms. Acta Neuropathol (2012) 1.14
T and B lymphocyte abnormalities in bone marrow biopsies of common variable immunodeficiency. Blood (2011) 1.13
Vicinal disulfide bridge conformers by experimental methods and by ab initio and DFT molecular computations. Proteins (2004) 1.13
Embryo-induced transcriptome changes in bovine endometrium reveal species-specific and common molecular markers of uterine receptivity. Reproduction (2006) 1.12
The major vault protein is responsive to and interferes with interferon-gamma-mediated STAT1 signals. J Cell Sci (2006) 1.12
Keeping the vimentin network under control: cell-matrix adhesion-associated plectin 1f affects cell shape and polarity of fibroblasts. Mol Biol Cell (2010) 1.12
Floral isolation is the main reproductive barrier among closely related sexually deceptive orchids. Evolution (2011) 1.11
Targeting of eEF1A with Amaryllidaceae isocarbostyrils as a strategy to combat melanomas. FASEB J (2010) 1.10
The activin axis in liver biology and disease. Mutat Res (2006) 1.10
Expression and functional activity of the ABC-transporter proteins P-glycoprotein and multidrug-resistance protein 1 in human brain tumor cells and astrocytes. J Neurooncol (2002) 1.10
Actin-binding domain of mouse plectin. Crystal structure and binding to vimentin. Eur J Biochem (2004) 1.10
O6-Methylguanine DNA methyltransferase protein expression in tumor cells predicts outcome of temozolomide therapy in glioblastoma patients. Neuro Oncol (2009) 1.09
Disorganization of the desmin cytoskeleton and mitochondrial dysfunction in plectin-related epidermolysis bullosa simplex with muscular dystrophy. J Neuropathol Exp Neurol (2002) 1.09
Atom depth in protein structure and function. Trends Biochem Sci (2003) 1.09
Metal-based paullones as putative CDK inhibitors for antitumor chemotherapy. J Med Chem (2007) 1.09
Seven novel and stable translocations associated with oncogenic gene expression in malignant melanoma. Neoplasia (2005) 1.08
Structure-activity relationship analysis of novel derivatives of narciclasine (an Amaryllidaceae isocarbostyril derivative) as potential anticancer agents. J Med Chem (2009) 1.08
Galectin 1 proangiogenic and promigratory effects in the Hs683 oligodendroglioma model are partly mediated through the control of BEX2 expression. Neoplasia (2009) 1.07
Prognostic significance of telomerase-associated parameters in glioblastoma: effect of patient age. Neuro Oncol (2013) 1.07
FGF18 in colorectal tumour cells: autocrine and paracrine effects. Carcinogenesis (2007) 1.06
Five birds, one stone: neutralization of α-hemolysin and 4 bi-component leukocidins of Staphylococcus aureus with a single human monoclonal antibody. MAbs (2015) 1.06
Stomatin is a major lipid-raft component of platelet alpha granules. Blood (2002) 1.06
Microtubule-associated protein 1A (MAP1A) and MAP1B: light chains determine distinct functional properties. J Neurosci (2002) 1.05
The PI3 kinase/mTOR blocker NVP-BEZ235 overrides resistance against irreversible ErbB inhibitors in breast cancer cells. Breast Cancer Res Treat (2010) 1.05
Up-regulation of the fibroblast growth factor 8 subfamily in human hepatocellular carcinoma for cell survival and neoangiogenesis. Hepatology (2011) 1.04
A site-specific plectin mutation causes dominant epidermolysis bullosa simplex Ogna: two identical de novo mutations. J Invest Dermatol (2002) 1.03
Differential effects of polymorphic alleles of FGF receptor 4 on colon cancer growth and metastasis. Cancer Res (2012) 1.03
Organometallic indolo[3,2-c]quinolines versus indolo[3,2-d]benzazepines: synthesis, structural and spectroscopic characterization, and biological efficacy. J Biol Inorg Chem (2010) 1.03
The role of costimulation in antibody deficiencies: ICOS and common variable immunodeficiency. Immunol Rev (2009) 1.03
Mutations in the gene encoding the PML nuclear body protein Sp110 are associated with immunodeficiency and hepatic veno-occlusive disease. Nat Genet (2006) 1.03
Mechanisms underlying the anticancer activities of the angucycline landomycin E. Biochem Pharmacol (2007) 1.03
Plectin. Methods Cell Biol (2004) 1.01
Anticancer activity of the lanthanum compound [tris(1,10-phenanthroline)lanthanum(III)]trithiocyanate (KP772; FFC24). Biochem Pharmacol (2005) 1.01
Targeted ablation of plectin isoform 1 uncovers role of cytolinker proteins in leukocyte recruitment. Proc Natl Acad Sci U S A (2005) 1.01